Treatment
Human Urinary Kallidinogenase clinical trials
We’re tracking 4 recruiting studies that include Human Urinary Kallidinogenase, each written for real people, not researchers, below.
Recruiting studies
- NCT06211712Recruiting
Drug plus clot removal for large vessel stroke
This study tests whether adding a drug called human urinary kallidinogenase to standard clot-removal therapy helps people recover better after a large-vessel stroke. If you qualify, you would receive the drug or a placebo by IV along with the procedure, and doctors will monitor your recovery.
ShanghaiAges 18 years+ - NCT06696703Recruiting
Human urinary kallidinogenase for acute ischemic stroke
This trial tests whether a medicine called human urinary kallidinogenase can reduce inflammation after a stroke. It may help people who have had a first or recent stroke and have certain levels of disability.
Harbin, HeilongjiangAges 18 years+ - NCT06848894Recruiting
Study of a drug for stroke patients after blood clot treatment
This trial tests if adding a drug called human urinary kallidinogenase (HUK) can improve recovery for people who have had a stroke and already received clot-busting medicine or a procedure to remove the clot. The goal is to see if it helps reduce disability after a stroke.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07283159RecruitingPhase 2
Tenecteplase plus a second drug for stroke recovery
This study tests whether giving a second drug (urinary kallidinogenase) after the clot-busting drug tenecteplase can help people with moderate to severe ischemic strokes recover better. It is for patients who started treatment within 4.5 hours of symptoms.
ShenyangAges 18 years+
What Human Urinary Kallidinogenase is being studied for
Conditions with recruiting Human Urinary Kallidinogenase studies.
Common questions
- Are there clinical trials studying Human Urinary Kallidinogenase?
- Yes. Clin2 currently lists 4 recruiting studies that include Human Urinary Kallidinogenase, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Human Urinary Kallidinogenase trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Human Urinary Kallidinogenase an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Human Urinary Kallidinogenase or a specific trial is right for you.
Related treatments
- Human Umbilical Cord Mesenchymal Stem Cells
- Human albumin
- Recombinant Human Growth Hormone
- Human Dopaminergic Progenitor Cells
- Rituximab and Hyaluronidase Human
- Recombinant Human Adenovirus Type 5
- Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1
- Recombinant human erythropoietin
- Pembrolizumab
- Cyclophosphamide
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.